Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brain

Immunobiology

Volumn 218, Issue 5, 2013, Pages 696-705

  De Vocht, Nathalie ^a   Lin, Dan ^a,b   Praet, Jelle ^a   Hoornaert, Chloé ^a   Reekmans, Kristien ^a   Le Blon, Debbie ^a   Daans, Jasmijn ^a   Pauwels, Patrick ^a   Goossens, Herman ^a   Hens, Niel ^a,b   Berneman, Zwi ^a   Van der Linden, Annemie ^a   Ponsaerts, Peter ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

Astrocytes; Brain; Cell transplantation; Mesenchymal stromal cell; Microglia

Indexed keywords

CALCIUM BINDING PROTEIN; CD11B ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; IONISED CALCIUM BINDING ADAPTOR MOLECULE 1; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BIOLUMINESCENCE; CELL DENSITY; CELL TRANSPLANTATION; CONTROLLED STUDY; ENZYME REPRESSION; GRAFT SURVIVAL; HISTOLOGY; INNATE IMMUNITY; MALE; MESENCHYMAL STROMA CELL; MICROGLIA; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ANIMALS; ANTIGENS, CD11B; ASTROCYTES; BRAIN; CELL COUNT; CELLS, CULTURED; GENE EXPRESSION; GENES, REPORTER; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; LUCIFERASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; TRANSPLANTATION, AUTOLOGOUS;

EID: 84875652067     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.08.266     Document Type: Article

References (37)

1. Bai L., Lennon D.P., Eaton V., Maier K., Caplan A.I., Miller S.D., Miller R.H. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009, 57:1192.
2. Barker C.F., Billingham R.E. Immunologically privileged sites. Adv. Immunol. 1977, 25:1.
3. Baron F., Storb R. Mensenchymal stromal cells: a new tool against graft-versus-host disease?. Biol. Blood Marrow Transplant. 2011.
4. Bergwerf I., De Vocht N., Tambuyzer B., Verschueren J., Reekmans K., Daans J., Ibrahimi A., Van Tendeloo V., Chatterjee S., Goossens H., Jorens P.G., Baekelandt V., Ysebaert D., Van Marck E., Berneman Z.N., Linden A.V., Ponsaerts P. Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. BMC Biotechnol. 2009, 9:1.
5. Bergwerf I., Tambuyzer B., De Vocht N., Reekmans K., Praet J., Daans J., Chatterjee S., Pauwels P., Van der Linden A., Berneman Z.N., Ponsaerts P. Recognition of cellular implants by the brain's innate immune system. Immunol. Cell Biol. 2011, 89:511.
6. Burns T.C., Verfaillie C.M., Low W.C. Stem cells for ischemic brain injury: a critical review. J. Comp. Neurol. 2009, 515:125.
7. Carson M.J., Doose J.M., Melchior B., Schmid C.D., Ploix C.C. CNS immune privilege: hiding in plain sight. Immunol. Rev. 2006, 213:48.
8. Czeh M., Gressens P., Kaindl A.M. The yin and yang of microglia. Dev. Neurosci. 2011, 33:199.
9. De Vocht N., Bergwerf I., Vanhoutte G., Daans J., De Visscher G., Chatterjee S., Pauwels P., Berneman Z., Ponsaerts P., Van der Linden A. Labeling of luciferase/eGFP-expressing bone marrow-derived stromal cells with fluorescent micron-sized iron oxide particles improves quantitative and qualitative multimodal imaging of cellular grafts in vivo. Mol. Imaging Biol. 2011.
10. De Vocht N., Reekmans K., Bergwerf I., Praet J., Hoornaert C., Le Blon D., Daans J., Berneman Z., Van der Linden A., Ponsaerts P. Multimodal imaging of stem cell implantation in the central nervous system of mice. J. Vis. Exp. 2012.
11. Dunnett S.B., Rosser A.E. Clinical translation of cell transplantation in the brain. Curr. Opin. Organ. Transplant. 2011, 16:632.
12. Durante W., Johnson F.K., Johnson R.A. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin. Exp. Pharmacol. Physiol. 2007, 34:906.
13. Gabrusiewicz K., Ellert-Miklaszewska A., Lipko M., Sielska M., Frankowska M., Kaminska B. Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS ONE 2011, 6:e23902.
14. Giunti D., Parodi B., Usai C., Vergani L., Casazza S., Bruzzone S., Mancardi G., Uccelli A. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells 2012.
15. Griffin M., Iqbal S.A., Bayat A. Exploring the application of mesenchymal stem cells in bone repair and regeneration. J. Bone Joint Surg. Br. 2011, 93:427.
16. Kan I., Melamed E., Offen D. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases. Handb. Exp. Pharmacol. 2007, 180:219.
17. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435.
18. Kim H.J. Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons. Biochim. Biophys. Acta 2011, 1812:1.
19. Kim J.Y., Kim D.H., Kim J.H., Lee D., Jeon H.B., Kwon S.J., Kim S.M., Yoo Y.J., Lee E.H., Choi S.J., Seo S.W., Lee J.I., Na D.L., Yang Y.S., Oh W., Chang J.W. Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-beta plaques. Cell Death Differ. 2012, 19:680.
20. Lee H.J., Lee J.K., Lee H., Carter J.E., Chang J.W., Oh W., Yang Y.S., Suh J.G., Lee B.H., Jin H.K., Bae J.S. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol. Aging 2012, 33:588.
21. Lee J.K., Schuchman E.H., Jin H.K., Bae J.S. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid beta ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells 2012, 30:1544.
22. Lowenstein C.J., Padalko E. iNOS (NOS2) at a glance. J. Cell Sci. 2004, 117:2865.
23. Lynch M.A. The multifaceted profile of activated microglia. Mol. Neurobiol. 2009, 40:139.
24. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453.
25. Nakajima H., Uchida K., Guerrero A.R., Watanabe S., Sugita D., Takeura N., Yoshida A., Long G., Wright K.T., Johnson W.E., Baba H. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J. Neurotrauma 2012, 29:1614.
26. Ooi Y.Y., Ramasamy R., Rahmat Z., Subramaiam H., Tan S.W., Abdullah M., Israf D.A., Vidyadaran S. Bone marrow-derived mesenchymal stem cells modulate BV2 microglia responses to lipopolysaccharide. Int. Immunopharmacol. 2010, 10:1532.
27. Orlacchio A., Bernardi G., Martino S. Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. Curr. Med. Chem. 2010, 17:595.
28. Praet J., Reekmans K., Lin D., De Vocht N., Bergwerf I., Tambuyzer B., Daans J., Hens N., Goossens H., Pauwels P., Berneman Z., Van der Linden A., Ponsaerts P. Cell type-associated differences in migration, survival and immunogenicity following grafting in CNS tissue. Cell Transplant. 2012.
29. Reekmans K.P., Praet J., De Vocht N., Tambuyzer B.R., Bergwerf I., Daans J., Baekelandt V., Vanhoutte G., Goossens H., Jorens P.G., Ysebaert D.K., Chatterjee S., Pauwels P., Van Marck E., Berneman Z.N., Van der Linden A., Ponsaerts P. Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice?. Cell Transplant. 2011, 20:851.
30. Ronsyn M.W., Daans J., Spaepen G., Chatterjee S., Vermeulen K., D'Haese P., Van Tendeloo V.F., Van Marck E., Ysebaert D., Berneman Z.N., Jorens P.G., Ponsaerts P. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol. 2007, 7:90.
31. Ronsyn M.W., Berneman Z.N., Van Tendeloo V.F., Jorens P.G., Ponsaerts P. Can cell therapy heal a spinal cord injury?. Spinal Cord 2008, 46:532.
32. Rosser A.E., Zietlow R., Dunnett S.B. Stem cell transplantation for neurodegenerative diseases. Curr. Opin. Neurol. 2007, 20:688.
33. Saino O., Taguchi A., Nakagomi T., Nakano-Doi A., Kashiwamura S., Doe N., Nakagomi N., Soma T., Yoshikawa H., Stern D.M., Okamura H., Matsuyama T. Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. J. Neurosci. Res. 2010, 88:2385.
34. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 1999, 57:563.
35. Tambuyzer B.R., Bergwerf I., De Vocht N., Reekmans K., Daans J., Jorens P.G., Goossens H., Ysebaert D.K., Chatterjee S., Van Marck E., Berneman Z.N., Ponsaerts P. Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol. Cell Biol. 2009, 87:267.
36. Torrente Y., Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant. 2008, 17:1103.
37. Wang Y., Piao J.H., Larsen E.C., Kondo Y., Duncan I.D. Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation. J. Neurosci. Res. 2011, 89:1737.